Invention Grant
- Patent Title: Substituted propane phosphinic acid derivatives
- Patent Title (中): 取代的丙烷次膦酸衍生物
-
Application No.: US13454643Application Date: 2012-04-24
-
Publication No.: US08828974B2Publication Date: 2014-09-09
- Inventor: Yong Mi Choi-Sledeski , Julian Levell , Gregory Bernard Poli , Mark Czekaj , Alan John Collis , Roy Vaz
- Applicant: Yong Mi Choi-Sledeski , Julian Levell , Gregory Bernard Poli , Mark Czekaj , Alan John Collis , Roy Vaz
- Applicant Address: US NJ Bridgewater
- Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee Address: US NJ Bridgewater
- Agent Kelly L. Bender
- Main IPC: A01N57/00
- IPC: A01N57/00 ; A61K31/675 ; C07C229/00 ; C07F9/28 ; C07F9/06 ; C07F9/02 ; C07F9/547 ; C07F9/6506 ; C07K5/08 ; C07F9/30 ; C07K5/06 ; C07F9/6503 ; C07F9/572 ; A61K38/00
Abstract:
The present invention relates to a series of substituted 3-aminopropane phosphinic acid derivatives of formula I: wherein R, R1, P1, P2 and P3 are as defined herein. The compounds of this invention are useful in treating a variety of diseases including but not limited to depression, anxiety, certain psychiatric symptoms, cognitive impairment and schizophrenia.
Public/Granted literature
- US20120208784A1 SUBSTITUTED PROPANE PHOSPHINIC ACID DERIVATIVES Public/Granted day:2012-08-16
Information query
